You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Battery-Powered, Portable Oxygen Generator for Injured Soldiers

    SBC: HIFUNDA LLC            Topic: DHP15010

    There is an important need for lightweight, reliable, portable oxygen generators to stabilize soldiers injured in the field prior to being brought into field hospitals. Injuries sustained in the field with significant bleeding lack readily available blood replacement or compressed oxygen which can lead to permanent disability or death. It is well known that high-purity oxygen can be used as a trea ...

    SBIR Phase I 2016 Department of DefenseDefense Health Agency
  2. Biomimetic Slope Adaptive Foot-Ankle Prosthesis

    SBC: MOTION CONTROL, INC            Topic: DHP16C007

    Biomimetic Slope Adaptive Foot-Ankle Prosthesis This project will develop an innovative mechanical/hydraulic foot-ankle system that will help lower extremity prosthesis wearers to walk or run in a wider range of environments with close to normal walking biomechanics. The proposed system will have a unique combination of features, all mechanically implemented without electronics or external powe ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
  3. Hemostatic Agent Development

    SBC: HYBRID PLASTICS            Topic: N101085

    The proposed effort aims to increase the TRL of the hemostatic agent through completion of relevant animal and toxicological research and development. These advancements will be verified through process improvements to meet good manufacturing practices.

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  4. Novel Biologic Countermeasure for Acute Radiation Syndrome

    SBC: Technology Holding, LLC            Topic: DHA201002

    Acute Radiation Syndrome (ARS) is an acute illness caused by irradiation of the entire body (or most of the body) by a high dose of penetrating radiation in a very short period of time. Global proliferation of radioactive and nuclear materials has resulted in increased threat of weaponized exposure or inadvertent exposure resulting from accidents such as Chernobyl. Presence of nuclear weapons with ...

    SBIR Phase I 2020 Department of DefenseDefense Health Agency
  5. Development of a Clinically Feasible Toolset to Optimize Performance and Mitigate Falls in Warfighters with Lower Limb Trauma and/or Loss

    SBC: Treadmetrix, LLC            Topic: DHA201D002

    Our group is well positioned to succeed in producing each deliverable outlined in DHA201-D002. Our key collaborator in this proposal, Mayo Clinic, has produced an outstanding body work through many years of research and development. Their impressive body of work on fall mitigation training has already demonstrated success for warfighters recovering from limb loss. Treadmetrix has a proven track re ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  6. Development of Human Monoclonal Antibody Therapeutic against Klebsiella pneumoniae Infection

    SBC: Technology Holding, LLC            Topic: DHA202003

    Antibiotic resistant infections are a principal concern for the Department of Defense and society at large due to the current lack of available treatments. Monoclonal antibodies represent a promising drug class that could be applied to antibiotic resistant infections to harness a patients own immune system to effectively combat the invading threat. In this program we present an optimized workflow ...

    SBIR Phase I 2021 Department of DefenseDefense Health Agency
  7. Biomimetic Slope Adaptive Foot-Ankle Prosthesis

    SBC: MOTION CONTROL, INC            Topic: DHP16C007

    The primary objectiveis to develop acommercially-viable prototype of theslopeadaptive prosthesis design and to iteratively improvethe design based on ISO standards testingand rigorous usein human subject field trials. The proposed work will build upon knowledgegained in PhaseI of the project,which established feasibility for this design approach in alightweight, passive hydraulicfoot-anklesystem. ...

    STTR Phase II 2022 Department of DefenseDefense Health Agency
  8. Medical Sterilizer for Far Forward Austere Environments

    SBC: Technology Holding, LLC            Topic: DHA213006

    The current steam based sterilizers have weight and power related challenges that limits their use to Role 3 environments. Further, due to high temperature of use, these are unsuitable for non-metallic objects such as medical scopes. The proposing team will develop a sterilizer for far forward austere Role 2 environments. The sterilizer uses modalities such that it can be used for sterilization of ...

    SBIR Phase I 2022 Department of DefenseDefense Health Agency
  9. Novel Biologic Countermeasure for Acute Radiation Syndrome

    SBC: Technology Holding, LLC            Topic: DHA201002

    Acute Radiation Syndrome (ARS) is an acute illness caused by irradiation of a significant portion of the body by a high dose of ionizing radiation (IR) in a short period of time. Global proliferation of radioactive and nuclear materials has resulted in increased threat of weaponized exposure or inadvertent exposure resulting from industrial accidents such as the case with the Chernobyl Nuclear Pow ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  10. Development of Human Monoclonal Antibody Therapeutic Against Klebsiella pneumoniae Infection

    SBC: Technology Holding, LLC            Topic: DHA202003

    Antibiotic resistant infections are a principal concern for the Department of Defense and society at large due to the current lack of available treatments. Monoclonal antibodies represent a promising drug class that could be applied to antibiotic resistant infections to harness a patients own immune system to effectively combat the invading threat. In this program we continue program development t ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government